Quantum Dots in Bioimaging: Advances, Challenges, and Future Perspectives

Abstract

Quantum dots (QDs) are size-dependent semiconductor crystal fluorescent markers at the nanoscale, which have revolutionized biomedical imaging through enhanced photostability, multiplexing, and emission-spectrum tunability. QDs, in the last two decades, have proved their utility across several types of imaging applications, ranging from in vitro labeling to deep-tissue visualization and tracking living cells. But their clinical use is limited because of their toxicity, long-term biocompatibility, and complicated surface modification. This is a narrative overview of the synthesis and structural engineering of QDs, including bottom-up chemical approaches, core–shell engineering, and biomedical compatibility surface modifications. The article also addresses the significant characterization methods—like TEM, DLS, PL spectroscopy, and zeta potential analysis—that are critical for evaluating their morphology, optical, and surface characteristics. Biomedical applications are classified as in vitro, in vivo, and molecular targeting imaging, each with specific requirements and challenges for performance. QDs hold promise, but they suffer from important hurdles, including toxic effects of heavy metals, photoxicity, and inefficient clearance from biological systems, as well as restricted regulatory endorsement. Future directions, including metal-free QDs, AI-based fluorescence analysis, and compatibility with multimodal imaging platforms, are discussed in this review as well. They seek to bypass the hurdles and propel QDs toward clinic readiness. In conclusion, quantum dots represent a powerful yet evolving imaging technology. Their future lies in balancing performance with safety through interdisciplinary research, material innovation, and ethical oversight.